1. Libert, N, Bigaillon, C, Chargari, C, et al. Epstein-Barr virus reactivation in critically ill immunocompetent patients. Biomed J. 2015;38(1):70–76. doi:10.4103/2319-4170.132905
Google Scholar | Crossref | Medline2. Ong, DSY, Bonten, MJM, Spitoni, C, et al. Epidemiology of multiple herpes viremia in previously immunocompetent patients with septic shock. Clin Infect Dis. 2017;64(9):1204-1210. doi:10.1093/cid/cix120
Google Scholar | Crossref | Medline3. Walton, AH, Muenzer, JT, Rasche, D, et al. Reactivation of multiple viruses in patients with sepsis. PLoS One. 2014;9(6):1-13. doi:10.1371/journal.pone.0098819
Google Scholar | Crossref4. Textoris, J, Mallet, F. Immunosuppression and herpes viral reactivation in intensive care unit patients: one size does not fit all. Crit Care. 2017;21(1):1-2. doi:10.1186/s13054-017-1803-1
Google Scholar | Crossref | Medline5. Chiche, L, Forel, J-M, Roch, A, et al. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients*. Crit Care Med. 2009;37(6):1850-1857. doi:10.1186/s13613-020-00793-2
Google Scholar | Crossref | Medline6. García-Martínez, FJ, Moreno-Artero, E, Jahnke, S. SARS-CoV-2 and EBV coinfection. Med Clín. 2020;155(7):319-320. doi:10.1016/j.medcle.2020.06.010
Google Scholar | Crossref | Medline7. Simonnet, A, Engelmann, I, Moreau, A-S, et al. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19. Infect Dis Now. 2021;51(3):296-299. doi:10.1016/j.idnow.2021.01.005
Google Scholar | Crossref | Medline8. Paolucci, S, Cassaniti, I, Novazzi, F, et al. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. Int J Infect Dis. 2021;104:315-319. doi:10.1016/j.ijid.2020.12.051
Google Scholar | Crossref | Medline9. Saade, A, Moratelli, G, Azoulay, E, Darmon, M. Herpesvirus reactivation during severe COVID-19 and high rate of immune defect. Infect Dis Now. 2021;S2666-S9919(21):000468-1. doi:10.1016/j.idnow.2021.07.005
Google Scholar | Crossref10. Lehner, GF, Klein, SJ, Zoller, H, Peer, A, Bellmann, R, Joannidis, M. Correlation of interleukin-6 with Epstein-Barr virus levels in COVID-19. Crit Care. 2020;24(1):657. doi:10.1186/s13054-020-03384-6
Google Scholar | Crossref | Medline11. Limaye, AP, Boeckh, M. CMV In critically ill patients: pathogen or bystander? Rev Med Virol. 2010;20(6):372-379. doi:10.1002/rmv.664
Google Scholar | Crossref | Medline12. Papazian, L, Jaber, S, Hraiech, S, et al. Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation. Ann Intensive Care. 2021;11(1):33. doi:10.1186/s13613-020-00793-2
Google Scholar | Crossref | Medline13. Kanakry, J, Ambinder, R. The biology and clinical utility of EBV monitoring in blood. Curr Top Microbiol Immunol. 2015;391:475-499. doi:10.1007/978-3-319-22834-1_17
Google Scholar | Crossref | Medline14. Group, TRC . Dexamethasone in hospitalized patients with covid-19. N Engl J Med. 2021;384(8):693-704. doi:10.1056/NEJMoa2021436
Google Scholar | Crossref | Medline